Active Pharmaceutical Ingredient Market 2017 Active Pharmaceutical Ingredient Market | Page 2

Geographies discussed and analyzed in the global active pharmaceutical ingredients market include North
America, Europe, Asia Pacific, and Rest of the World. In addition the report also comprises the precise and
detailed country wise analysis for the global active pharmaceutical ingredients market such as North
America (U.S. and Canada), Asia Pacific (China, Japan, India and Rest of Asia Pacific), and Europe (Germany,
U.K. and Rest of Europe). The market size and forecast in terms of US$ Mn for each segment has been
provided for the period from 2013 to 2023. The report on the active pharmaceutical ingredients market
also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above
for the forecast period from 2015 to 2023, considering 2014 as the base year.
To Get Full Detail of The Reports @ http://www.transparencymarketresearch.com/active-
pharmaceutical-ingredients.html
A list of recommendations have been provided for new entrants to help establish a strong presence and
for existing market players to take strategic decisions and to increase their market shares in the global
active pharmaceutical ingredient market. The report concludes with the profiles of major players in the
active pharmaceutical ingredients market based on various attributes such as company overview, financial
overview, business strategies, product portfolio, and recent developments. Major players profiled in this
report include Allergan plc, BASF SE, Boehringer Ingelheim Group, Cambrex Corporation, Dr. Reddy’s
Laboratories Ltd., Lonza Group, Mylan, Inc., Sandoz (Novartis AG), Pfizer, Inc., Teva Pharmaceutical
Industries Ltd., and WuXi Apptec.
The global active pharmaceutical ingredients market is segmented as follows:
Global Active Pharmaceutical Ingredients Market, by Manufacturing Process, 2013-2023 (US$ Mn)
 Captive Manufacturing
 Contract Manufacturing
Global Active Pharmaceutical Ingredients Market, by API Type, 2013 – 2023 (US$ Mn)
 Synthetic Chemical API
 Biological API
Global Active Pharmaceutical Ingredients Market, by Drug Type, 2013 – 2023 (US$ Mn)
 Branded Prescription Drugs
 Generic Prescription Drugs
 OTC Prescription Drugs
Global Active Pharmaceutical Ingredients Market, by Therapeutic Area, 2013 – 2023 (US$ Mn)
 Cardiovascular Disorders
 Metabolic Disorders
 Neurological Disorders
 Oncology
 Musculoskeletal Disorders
 NSAIDs
 Other Therapeutics Uses
Global Active P